Skip to content

Meet with Taconic Biosciences at the 7th Annual Asia Pacific ISSX Meeting!

January 29 - February 1, 2023

Join Taconic and Nomura Siam International (NSI) at the 7th Annual Asia Pacific ISSX Meeting! Taconic Field Application Scientist Dr. Ivan Gladwyn-Ng will join NSI staff in Bangalore for the first AP-ISSX meeting to held in India. The theme of the 2023 AP-ISSX meeting is "innovative approaches in translational ADMET science for accelerating drug discovery and development".
 
Stop by the NSI booth to find out how Taconic GEM models can accelerate both discovery and development. The rasH2 carcinogenicity test system can cut down the timeline for mouse carcinogenicity testing by 75%, and the latest revisions to the ICH S1B guidelines open the door to potentially reducing the overall timeline to new drug approval by 2 years when using rasH2.
 
Taconic's portfolio of exclusive GEM models includes knockout and humanized mouse models for drug transporters, cytochrome P450s and xenoreceptors. These models allow in vivo study of drug-drug interactions, human metabolite production, drug distribution and metabolism and more.
 
Complete the form to request a 1:1 meeting with Dr. Ivan Gladwyn-Ng to discuss how Taconic's products and services can support you in accelerating drug discovery and development. We hope to see you there!
 

Dr. Ivan Gladwyn-Ng

Associate Director, Field Application Sciences

Ivan is an Associate Director of Field Applications Sciences at Taconic Biosciences who has been utilizing rodent models within many diverse fields of pre-clinical research. He is passionate about accelerating advancements in human health by improving the care and application of in vivo animal models in the drug discovery process, and particularly engaged with oncological and infectious as well as metabolic and neurological translational preclinical research. Ivan has led multi-disciplinary research teams with global collaborations in laboratories from diverse parts of the world, as adjunct researcher and post-doctoral research fellow in the Institut Pasteur (Paris, France), Harry Perkins Institute of Medical Research (Perth, Australia) and the GIGA Institute (Liege, Belgium). He has multiple co-first & co-last authorships in Nature Research, Cell Press, Science and Frontiers publications as well as patent applications in Europe and USA. Prior to these, Ivan was conferred his doctorate at the Australian Regenerative Medicine Institute (Melbourne, Australia), with First-Class Honours (top student) after completing his undergraduate studies (B.Sc. (Med.) at the Monash University.

Schedule a Meeting

© 2025 Taconic Biosciences, Inc. All rights reserved.

Consent Preferences